Press release
Typhoid Vi Polysaccharide Vaccine Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | Sanofi Pasteur SA, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited
Typhoid Vi Polysaccharide Vaccine Market Trends
The Business Research Company offers in-depth market insights through Typhoid Vi Polysaccharide Vaccine Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The typhoid vi polysaccharide vaccine market size has grown rapidly in recent years. It will grow from $4.98 billion in 2023 to $5.84 billion in 2024 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to disease prevalence, global health initiatives, traveler vaccination, government immunization efforts, vaccine efficacy and safety..
The typhoid vi polysaccharide vaccine market size is expected to see rapid growth in the next few years. It will grow to $11.28 billion in 2028 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to expanded immunization programs, global health policy focus, epidemiological surveillance, rising demand in travel medicine, environmental and social factors.. Major trends in the forecast period include r&d investments, regulatory support, epidemiological studies, public health awareness..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=8313&type=smp
Market Segmentation:
The typhoid vi polysaccharide vaccine market covered in this report is segmented -
1) By Type: Child, Adult
2) By Route of Administration: Oral, Parenteral
3) By Application: Government Institution, Private Sector, Other Applications
Major Driver - Escalating Typhoid Prevalence Fuels Expansion In The Typhoid Vi Polysaccharide Vaccine Market
Rising typhoid prevalence is expected to propel the growth of the typhoid VI polysaccharide vaccine market going forward. Typhoid is an infection caused by the bacteria Salmonella typhi that can be fatal. It usually spreads through contaminated food or drink. Typhoid Vi polysaccharide vaccine is used to immunise adults and children aged 2 and up against typhoid fever caused by Salmonella enterica serovar Typhi, S. Typhi. For instance, in March 2021, according to a report shared by the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, infections with Salmonella Typhi were believed to affect 5,700 Americans annually, with 620 of these likely to require hospitalization. Typhoid fever mostly causes between 11 and 21 million cases worldwide every year, along with 200,000 fatalities. Therefore, the rising typhoid prevalence is driving the growth of the typhoid Vi polysaccharide vaccine market.
Competitive Landscape:
Major companies operating in the typhoid vi polysaccharide vaccine market report are Sanofi Pasteur SA, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Emergent Biosolutions Inc., PT Bio Farma, Bharat Biotech International Limited, Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan NV, Serum Institute of India Pvt. Ltd., Biological E. Limited, Panacea Biotec Ltd., Shantha Biotechnics Pvt. Ltd., Cadila Healthcare Ltd., Merck Sharp & Dohme Corp., AstraZeneca Limited, Boryung Pharmaceutical Co., Bio-Med Pvt. Ltd., LG Chem, SK Chemicals Co. Ltd., Crucell Switzerland AG, Hualan Biological Engineering Inc., Indian Immunologicals Limited
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/typhoid-vi-polysaccharide-vaccine-global-market-report
Top Trend - International Vaccine Institute's Dynamic Partnerships With Moderna And Gsk Fuel Advances In Typhoid Vi Polysaccharide Vaccine Market
Strategic partnerships are a key trend gaining popularity in the typhoid Vi polysaccharide vaccine market. Major companies operating in the typhoid Vi polysaccharide vaccine market are entering into partnerships to strengthen their position in the typhoid Vi polysaccharide market. For instance, in July 2022, The International Vaccine Institute, a South Korea-based international organization focused on infectious diseases of global health importance such as cholera, typhoid, shigella, and salmonella, partnered with Moderna, a US-based biopharmaceutical company. This partnership led to the world's first affordable oral cholera vaccine and a new-generation typhoid conjugate vaccine.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Typhoid Vi Polysaccharide Vaccine Market Characteristics
3. Typhoid Vi Polysaccharide Vaccine Market Trends And Strategies
4. Typhoid Vi Polysaccharide Vaccine Market - Macro Economic Scenario
5. Typhoid Vi Polysaccharide Vaccine Market Size And Growth
…..
27. Typhoid Vi Polysaccharide Vaccine Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Typhoid Vi Polysaccharide Vaccine Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | Sanofi Pasteur SA, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited here
News-ID: 3423714 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Typhoid
What Is The Leading Driver Behind Escalating Typhoid Prevalence Fuels Expansion …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Typhoid Vi Polysaccharide Vaccine Industry Market Size Be by 2025?
The typhoid vi polysaccharide vaccine sector has experienced swift expansion recently, projecting a rise from a valuation of $5.78 billion in 2024 to $6.71 billion the subsequent year, reflecting a substantial compound annual growth rate of…
Leading Growth Driver in the Typhoid Antibody Testing Market in 2025: Increase I …
What Are the Market Size and Growth Forecast for the Typhoid Antibody Testing Market?
In recent times, the typhoid antibody testing market has experienced substantial growth. The market is projected to increase from $7.83 billion in 2024 to $8.46 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.2%. The historical growth rate can be linked to the growing collaboration efforts focused on creating new testing instruments, development…
Testing Advancements: Typhoid Antibody Detection Market Growth 2024
The Business Research Company recently released a comprehensive report on the Global Typhoid Antibody Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Breakthrough Testing: Advancements in Typhoid Antibody Detection
The Business Research Company recently released a comprehensive report on the Global Typhoid Antibody Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, the typhoid antibody testing…
Typhoid Vi Polysaccharide Vaccine Market Size & Forecast 2033
The new report published by The Business Research Company, titled ""Typhoid Vi Polysaccharide Vaccine Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the typhoid vi polysaccharide vaccine market size has grown rapidly in recent years. It will grow from…
Typhoid Vaccine Market is Thriving Worldwide with Top Companies like: Merck, Gla …
Los Angeles, United State, –The report titled Global Typhoid Vaccine Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Typhoid Vaccine market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global…
